AWM Investment Company, Inc. - Dec 13, 2021 Form 4 Insider Report for Recro Pharma, Inc. (SCTL)

Role
10%+ Owner
Signature
Adam Stettner
Stock symbol
SCTL
Transactions as of
Dec 13, 2021
Transactions value $
-$81,785
Form type
4
Date filed
12/15/2021, 03:42 PM
Previous filing
Dec 13, 2021
Next filing
Dec 16, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCTL Common Stock Sale -$32.5K -20K -0.38% $1.63 5.26M Dec 13, 2021 By Limited Partnerships F1
transaction SCTL Common Stock Sale -$16.7K -10.6K -0.2% $1.57 5.25M Dec 14, 2021 By Limited Partnerships F1
transaction SCTL Common Stock Sale -$32.6K -20K -0.38% $1.63 5.23M Dec 15, 2021 By Limited Partnerships F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is a weighted average price.
F2 AWM Investment Company, Inc., a Delaware Corporation (AWM), is the investment adviser to Special Situations Fund III QP, L.P. (QP), Special Situations Cayman Fund, L.P. (Cay) and Special Situations Private Equity Fund, L.P. (PE). (PE together with QP and Cay the Funds). As the investment adviser to the Funds, AWM holds sole voting and investment power over 3,265,741 shares of Common Stock of the Issuer (the Shares) held by QP, 1,140,727 Shares held by Cay and 824,831 Shares held by PE.
F3 Austin W. Marxe (Marxe), David M. Greenhouse (Greenhouse) and Adam C. Stettner (Stettner) are the controlling principals of AWM. The reporting person disclaims beneficial ownership of the Shares, except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that the reporting person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.